SUBSCRIBE
SUBSCRIBE
News   Drug Development

Bayer AG. Johnson & Johnson Anti-Clot Drug Gets Cautious Journal Welcome

August 11, 2011 | 
1 min read
An anti-clotting pill from Bayer and Johnson & Johnson offers a new way of preventing stroke although further studies will be needed to refine treatment options, according to a review in a top medical journal.
Clinical research Postmarket research
Johnson & Johnson Family of Companies
MORE ON THIS TOPIC
Insights
Programmable RNA 2.0: Beyond the First mRNA Revolution
February 5, 2026
 · 
1 min read
 · 
Jennifer Smith-Parker
Trend artwork 3D photo collage sketch image of young sad stressed lady with headache burnout deadline overloaded tired work in office.
Duchenne muscular dystrophy
Sarepta Saga Has ‘Gone on Too Long’ as Competitors Catch Up
February 5, 2026
 · 
5 min read
 · 
Dan Samorodnitsky
Successful businessman standing in front of multiple pathways, making a decision for the right move. A symbol of great investment and positive progress in the development of business. stock illustration
Immunology and inflammation
Lilly Eyes Pipeline in a Product as GLP-1s Move Into I&I
February 4, 2026
 · 
2 min read
 · 
Heather McKenzie
Podcast
Pfizer’s Metsera Data, 2025 Earnings, the FDA and REGENXBIO, Psychedelics and IPOs
February 4, 2026
 · 
1 min read
 · 
Heather McKenzie